Erythrocyte 2,3 diphosphoglycerate in normal and hypertensive gravid women and their newborn infants

  • R. R. Weiss
  • , M. S. Roginsky
  • , L. I. Mann
  • , A. Melber
  • , J. Bachorik
  • , N. Tejani
  • , A. Bhakthavathsalan
  • , M. I. Evans

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Red blood cell 2,3 diphosphoglycerate (2,3 DPG) levels were studied in 227 normal gravid women in all stages of pregnancy, active labor, and early post partum. An increase to peak levels was observed at 19 to 22 weeks followed by a gradual fall toward normal. During labor and early post partum, 2,3 DPG again rose significantly above levels observed at term. Serial 2,3 DPG values through the third trimester, labor, and postpartum period in 11 hypertensive mothers and 20 normal gravid control subjects and their newborn infants were studied. Maternal 2,3 DPG levels were significantly higher in the hypertensive mothers when compared to control mothers at similar gestational stages. However, no difference in 2,3 DPG levels was observed when newborn infants of hypertensive mothers were compared with those of normal control subjects.

Original languageEnglish
Pages (from-to)692-696
Number of pages5
JournalUnknown Journal
Volume124
Issue number7
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erythrocyte 2,3 diphosphoglycerate in normal and hypertensive gravid women and their newborn infants'. Together they form a unique fingerprint.

Cite this